Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today kicked off the enrollment for a Phase III clinical trial on a vaccine ...

Sinovac Biotech initiates phase ? trial on bivalent vaccine to treat hand foot and mouth disease: Beijing, China Tuesday, December 17, 2024, 18:00 Hrs [IST] Sinovac Biotech Ltd., ...